Tumor necrosis factor-α in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: Significance of core 2 GlcNAc-T in diabetic retinopathy

Diabetes

Volumn 53, Issue 11, 2004, Pages 2968-2976

  Ben Mahmud, Bahaedin M ^a   Mann, Giovanni E ^a   Datti, Alessandro ^b   Orlacchio, Aldo ^b   Kohner, Eva M ^c   Chibber, Rakesh ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ENZYME INHIBITOR; LY 379196; PROTEIN KINASE C; PROTEIN KINASE C BETA2; TRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BLOOD VESSEL OCCLUSION; CELL ADHESION; CELL STRAIN U937; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; CAPILLARIES; CELL ADHESION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN KINASE C; RECOMBINANT PROTEINS; RETINAL VESSELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 7044269436     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.11.2968     Document Type: Article

References (50)

1. Davis MD: Diabetic retinopathy: a clinical overview. Diabetes Care 15: 1844-1873, 1993
2. Kohner EM, Chibber R: Diabetic retinopathy. In Diabetic Angiopathy. JE Tooke, Ed. Oxford, U.K., Oxford University Press, 1999, p. 233-247
3. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A 96:10836-10841, 1999
4. Lutty GA, Cao J, Mcleod DS: Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151:707-714, 1997
5. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP: Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 158:147-152, 2001
6. Chibber R, Ben-Mahmud BM, Coppini D, Christ E, Kohner EM: Activity of core 2 GlcNAc (β1,6) transferase is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes 49:1724-1730, 2000
7. Fukuda M: Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573:394-405, 2002
8. Lowe JB: Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 186:19-36, 2002
9. Schachter H, Brochausen I: The biosynthesis of serine (threonine)-N-acetylgalactosamine-linked carbohydrate moieties. In Glyconjugates: Composition, Structure and Function. Allen HJ, Kisailus EC, Eds. New York, Marcel Dekker, 1992, p. 263-332
10. Chibber R, Ben-Mahmud BM, Mann GE, Zhang JJ, Kohner EM: Protein kinase C β2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes 52:1519-1527, 2003
11. Koya D, King G: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
12. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Miyamoto K, Nishiwaki H, Honda Y, Ogura Y: PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 41:2702-2706, 2000
13. Nishio Y, Warren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB Jr, Dennis JW, King GL: Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 96:1759-1767, 1995
14. Armstrong D, Augustin AJ, Spengler R, Al-Jada A, Nickola T, Grus F, Koch F: Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 212: 410-414, 1998
15. Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A: TNF-alpha level in the vitreous body: increase in neovascular eye diseases and proliferative diabetic retinopathy. Med Clin 90:134-137, 1995
16. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC: Distribution of TNF-alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 80:168-173, 1996
17. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP: Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438-440, 2002
18. Slepova OS, Gerasimenko VL, Zakharova GI, Novikova-Bilak TI: Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy [in Russian]. Vestn Oftalmol 117:35-37, 2001
19. Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N, Savli H: Comparison of plasma NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163-170, 2002
20. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J: Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis 62:472-475, 2003
21. Halasz A, Cserhati E, Kosa L, Cseh K: Relationship between the tumor necrosis factor system and the plasmainterleukin-4, interleukin-5, interleukin-8, eosinophil cationic protein, and immunoglobulin E levels in the bronchial hyperreactivity of adults and their children. Allergy Asthma Proc 24:111-118, 2003
22. Baugh JA, Bucala R: Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 4:635-650, 2001
23. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, Rabbani LE, Sacco RL: Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 33:31-37, 2002
24. Chibber R, Molinatti PA, Kohner EM: Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cell Mol Biol 45:47-57, 1999
25. Jain SK, Kannan K, Lim G, McVie R, Bocchini JA Jr: Hyperketonemia increases tumor necrosis factor-α secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51:2287-2293, 2002
26. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka YA: Synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun 166:1220-1227, 1990
27. VanderElst IE, Datti A: Beta1,6 N-acetylglucosaminyltransferase (core 2 GlcNAc-T) expression in normal rat tissues and different cell lines: evidence for complex mechanisms of regulation. Glycobiology 8:731-740, 1998
28. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
29. Hussain MJ, Peakman M, Gallati H, Lo SS, Hawa M, Viberti GC, Watkins PJ, Leslie RD, Vergani D: Elevated plasma levels of macrophage-derived cytokines precede and accompany the onset of 1DDM. Diabetologia 39:60-69, 1996
30. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F: Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 248:67-76, 2000
31. Cavallo MG, Pozzilli P, Bird C, Wadhwa M, Meager A, Visalli N, Gearing AJ, Andreani D, Thorpe R: Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 86:256-259, 1991
32. Piller F, Piller V, Fox RI, Fukuda M: Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem 263:15146-15150, 1988
33. Higgins EA, Siminovitch KA, Zhuang DL, Brockhausen I, Dennis JW: Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem 266:6280-6290, 1991
34. Vachino G, Chang XJ, Veldman GM, Kumar R, Sako D, Fouser LA, Berndt MC, Cumming DA: P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem 270:21966-21974, 1995
35. Moller B, Ellermann-Eriksen S, Storgaard M, Obel N, Bendtzen K, Petersen CM: Soluble tumor necrosis factor (TNF) receptors conserve TNF bioactivity in meningitis patient spinal fluid. J Infect Dis 174:557-563, 1996
36. Hehlgans T, Mannel DN: The TNF-TNF receptor system. Biol Chem 383:1581-1585, 2002
37. Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491-503, 1994
38. Sagara M, Satoh J, Zhu XP, Takahashi K, Fukuzawa M, Muto G, Muto Y, Toyota T: Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats. Clin Immunol Immunopathol 71:333-337, 1994
39. Tanaka S, Seino H, Satoh J, Fujii N, Rikiishi H, Zhu XP, Takahashi K, Sagara M, Nobunaga T, Toyota T: Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats. Clin Immunol Immunopathol 62:258-263, 1992
40. Renier G, Mamputu JC, Serri O: Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells. Metabotism 52:13-18, 2003
41. Sartippour MR, Renier G: Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes 49:597-602, 2000
42. Guha M, Bai W, Nadler J, Natarajan R: Molecular mechanisms of TNF-alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress dependent and independent pathways. J Biol Chem 275: 17728-17739, 2000
43. Kozawa O, Suzuki A, Kaida T, Tokuda H, Uematsu T: Tumor necrosis factor-alpha autoregulates interleukin-6 synthesis via activation of protein kinase C: function of sphingosine 1-phosphate and phosphatidylcholine-specific phospholipase C. J Biol Chem 272:25099-25104, 1997
44. Radeff JM, Nagy Z, Stern PH: Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Exp Cell Res 15:179-188, 2001
45. Datti A, Dennis J: Regulation of UDP-GlcNAc:Gal beta 1-3GalNAc-R beta 1-6-N-acetylglucosaminyltransferase (GlcNAc to GalNAc) in Chinese hamster ovary cells. J Biol Chem 268:5409-5416, 1993
46. Ferro TJ, Parker DM, Commins LM, Phillips PG, Johnson A: Tumor necrosis factor-alpha activates pulmonary artery endothelial protein kinase C. Am J Physiol 264:L9-L14, 1993
47. Gross ER, LaDisa JF Jr, Weihrauch D, Olson LE, Kress TT, Hettrick DA, Pagel PS, Warltier DC, Kersten JR: Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol 284:H1552-H1559, 2003
48. Kumar R, Camphausen RT, Sullivan FX, Cumming D: Core2 beta-1,6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood 88:3872-3879, 1996
49. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP: Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem 271:3255-3264, 1996
50. Bernimonlin MP, Zeng XL, Abbal C, Giraud S, Martinez M, Michielin O, Schapira M, Spertini O: Molecular basis of leukocyte rolling on PSGL-1: predominant role of core-2 O-glycans and of tyrosine sulfate residue 51. J Biol Chem 278:37-47, 2003